Posted On: 09/08/2014 7:19:49 AM
Post# of 63828
$CBLI new volume. Pr $0.58
Cleveland BioLabs and Sabby Announce Resolution of Litigation
2014-09-08 07:00 ET - News Release
Website
Shares Outstanding: 57.11M
Float: 49.35M
10-Q 8/11/14
56% Buy
Press Releases
Monday, September 8, 2014
Cleveland BioLabs and Sabby Announce Resolution of LitigationMarketwired
Wednesday, September 3, 2014
Cleveland BioLabs Announces Green Light to Submit Pre-Emergency Use Authorization Application for EntolimodMarketwired
Tuesday, September 2, 2014
Cleveland BioLabs to Report Outcome of July FDA Meeting and Host Conference Call on September 3Marketwired( (Tue, Sep 2)
Cleveland BioLabs to Present at Rodman & Renshaw 16th Annual Global Investment ConferenceMarketwired
Thursday, August 7, 2014
Cleveland BioLabs Reports Second Quarter 2014 Financial Results and Development ProgressMarketwired
Wednesday, August 6, 2014
Cleveland BioLabs to Host Second Quarter 2014 Earnings Conference Call and Webcast Live on Thursday, August 7, 2014Accesswire
Tuesday, July 29, 2014
Cleveland BioLabs to Report Second Quarter 2014 Financial Results and Provide Operational Update on August 7Marketwired
Wednesday, June 18, 2014
Cleveland BioLabs Reduces Debt With $3.5 Million At-the-Market Private Placement of Unregistered StockMarketwired
Friday, May 9, 2014
Cleveland BioLabs Announces Compensation Reductions for Co-Founders and Directors; New Board NomineesMarketwired
Thursday, May 8, 2014
Cleveland BioLabs Reports First Quarter 2014 Financial Results and Development ProgressMarketwired
Tuesday, April 29, 2014
Cleveland BioLabs to Report First Quarter 2014 Financial Results and Provide Operational Update on May 8Marketwired
Wednesday, April 16, 2014
Cleveland BioLabs Announces the Successful Completion of a Phase 1 Study of CBL0102Marketwired
Tuesday, April 1, 2014
CBL0137 Combination Studies to Be Presented at 2014 AACR Annual MeetingMarketwired
Cleveland BioLabs and Sabby Announce Resolution of Litigation
2014-09-08 07:00 ET - News Release
Website
Shares Outstanding: 57.11M
Float: 49.35M
10-Q 8/11/14
56% Buy
Press Releases
Monday, September 8, 2014
Cleveland BioLabs and Sabby Announce Resolution of LitigationMarketwired
Wednesday, September 3, 2014
Cleveland BioLabs Announces Green Light to Submit Pre-Emergency Use Authorization Application for EntolimodMarketwired
Tuesday, September 2, 2014
Cleveland BioLabs to Report Outcome of July FDA Meeting and Host Conference Call on September 3Marketwired( (Tue, Sep 2)
Cleveland BioLabs to Present at Rodman & Renshaw 16th Annual Global Investment ConferenceMarketwired
Thursday, August 7, 2014
Cleveland BioLabs Reports Second Quarter 2014 Financial Results and Development ProgressMarketwired
Wednesday, August 6, 2014
Cleveland BioLabs to Host Second Quarter 2014 Earnings Conference Call and Webcast Live on Thursday, August 7, 2014Accesswire
Tuesday, July 29, 2014
Cleveland BioLabs to Report Second Quarter 2014 Financial Results and Provide Operational Update on August 7Marketwired
Wednesday, June 18, 2014
Cleveland BioLabs Reduces Debt With $3.5 Million At-the-Market Private Placement of Unregistered StockMarketwired
Friday, May 9, 2014
Cleveland BioLabs Announces Compensation Reductions for Co-Founders and Directors; New Board NomineesMarketwired
Thursday, May 8, 2014
Cleveland BioLabs Reports First Quarter 2014 Financial Results and Development ProgressMarketwired
Tuesday, April 29, 2014
Cleveland BioLabs to Report First Quarter 2014 Financial Results and Provide Operational Update on May 8Marketwired
Wednesday, April 16, 2014
Cleveland BioLabs Announces the Successful Completion of a Phase 1 Study of CBL0102Marketwired
Tuesday, April 1, 2014
CBL0137 Combination Studies to Be Presented at 2014 AACR Annual MeetingMarketwired
(0)
(0)
